Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
November 17, 2022
Bright light therapy as a non-pharmacological treatment option for multiple sclerosis-related fatigue: A randomized sham-controlled trial
Lisa Voggenberger, Marion Böck, Doris Moser, et al.
European Journal of Neurology
|
November 4, 2020
Longitudinal measurement of cerebrospinal fluid neurofilament light in anti-N-methyl-D-aspartate receptor encephalitis
Stefan Macher, Tobias Zrzavy, Romana Höftberger, et al.
Digital Health
|
July 18, 2022
Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
Patrick Altmann, Fritz Leutmezer, Markus Ponleitner, et al.
Frontiers in Neurology
|
March 24, 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
Nik Krajnc, Patrick Altmann, Katharina Riedl, et al.
Acta Neurologica Scandinavica
|
November 18, 2018
Do elevated autoantibodies in patients with multiple sclerosis matter?
Assunta Dal-Bianco, Fritz Wenhoda, Paulus Stefan Rommer, et al.
International Journal of Environmental Research and Public Health
|
January 21, 2022
Individual Perception of Telehealth: Validation of a German Translation of the Telemedicine Perception Questionnaire and a Derived Short Version
Patrick Altmann, Dominik Ivkic, Markus Ponleitner, et al.
Digital Health
|
February 6, 2025
Cost-effectiveness of the Floodlight<sup>®</sup> MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis
Evelyn Walter, Matthäus Traunfellner, Franz Meyer, et al.
Scientific Reports
|
October 3, 2024
Investigation of serum neurofilament light chain as a biomarker in Fabry disease
Markus Ponleitner, Constantin Gatterer, Gabriel Bsteh, et al.
Journal of Neurology
|
September 15, 2020
Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
Tobias Monschein, Sabine Salhofer-Polanyi, Patrick Altmann, et al.
Wiener Klinische Wochenschrift
|
April 22, 2025
A randomized controlled pilot study investigating adherence to blood pressure diaries with personal pictures in stroke follow-up care
Clemens V Farr, Johanna Ebner, Marie Beatrice Lang, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
November 17, 2022
Bright light therapy as a non-pharmacological treatment option for multiple sclerosis-related fatigue: A randomized sham-controlled trial
Lisa Voggenberger, Marion Böck, Doris Moser, et al.
European Journal of Neurology
|
November 4, 2020
Longitudinal measurement of cerebrospinal fluid neurofilament light in anti-N-methyl-D-aspartate receptor encephalitis
Stefan Macher, Tobias Zrzavy, Romana Höftberger, et al.
Digital Health
|
July 18, 2022
Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
Patrick Altmann, Fritz Leutmezer, Markus Ponleitner, et al.
Frontiers in Neurology
|
March 24, 2022
Association of Cerebrospinal Fluid Parameters and Neurofilament Light Chain With Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
Nik Krajnc, Patrick Altmann, Katharina Riedl, et al.
Acta Neurologica Scandinavica
|
November 18, 2018
Do elevated autoantibodies in patients with multiple sclerosis matter?
Assunta Dal-Bianco, Fritz Wenhoda, Paulus Stefan Rommer, et al.
International Journal of Environmental Research and Public Health
|
January 21, 2022
Individual Perception of Telehealth: Validation of a German Translation of the Telemedicine Perception Questionnaire and a Derived Short Version
Patrick Altmann, Dominik Ivkic, Markus Ponleitner, et al.
Digital Health
|
February 6, 2025
Cost-effectiveness of the Floodlight<sup>®</sup> MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis
Evelyn Walter, Matthäus Traunfellner, Franz Meyer, et al.
Scientific Reports
|
October 3, 2024
Investigation of serum neurofilament light chain as a biomarker in Fabry disease
Markus Ponleitner, Constantin Gatterer, Gabriel Bsteh, et al.
Journal of Neurology
|
September 15, 2020
Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
Tobias Monschein, Sabine Salhofer-Polanyi, Patrick Altmann, et al.
Wiener Klinische Wochenschrift
|
April 22, 2025
A randomized controlled pilot study investigating adherence to blood pressure diaries with personal pictures in stroke follow-up care
Clemens V Farr, Johanna Ebner, Marie Beatrice Lang, et al.
Page
of 6